Molecular Subtypes of Breast Carcinoma and Their Association with Clinicopathological Features
DOI:
https://doi.org/10.36283/ziun-pjmd14-1/005Keywords:
Molecular Subtypes, Breast Cancer, Clinicopathological FeaturesAbstract
Background: Breast cancer is categorized into four primary molecular subtypes based on gene expression profiles and hormone receptor status: Luminal A & B subtypes, Basal-like, and HER2-enriched. This study assessed the association of molecular categories of breast carcinoma with the clinicopathological features.
Method: A cross-sectional study was conducted between January 2022 and August 2024; 200 mastectomy specimens were collected with a non-probability consecutive sampling technique from Ziauddin Hospital Histopathology Department in Karachi, Pakistan. Immunohistochemical analysis was done for ER, PR, HER 2 Neu, and Ki-67 and the findings were statistically analyzed for association with clinicopathological parameters.
Results: Luminal B subtype was found to be the most common subtype. The study identified pT2 and pT3 as the most frequent pathological stages, with 74 cases (38.1%) and 71 cases (34.4%), respectively. Low-grade tumors were less frequent as compared to intermediate and high-grade tumors with 11 (5.5%), 73(36.5%), and 116 cases (58.0%), respectively. A significant association was observed between molecular subtypes and tumor grade, stage, and histological subtypes. However, insignificant association was seen with age, laterality, and tumor site.
Conclusion: Luminal B tumor was the most frequent subtype, while luminal A was the least prevalent. Luminal B tumors were primarily associated with invasive ductal carcinoma invasive ductal carcinoma (NOS). These tumors were commonly found in women aged 41-50. Furthermore, a strong association of molecular subtypes was observed with histological grading and staging.
References
Momenimovahed Z, Salehiniya H. Epidemiological characteristics of and risk factors for breast cancer worldwide. Breast Cancer: Targets and Therapy. 2019 April;11, 151-64. https://doi.org/10.2147/BCTT.S176070
Fahad Ullah M. Breast cancer: current perspectives on the disease status. Breast Cancer Metastasis and Drug Resistance: Challenges and Progress. 2019 August; 51-64. https://doi.org/10.1007/978-3-030-20301-6_4
World Health Organization: WHO, https://www.who.int/news-room/fact-sheets/detail/breast-cancer?gad_source=1&gclid=CjwKCAjw9eO3BhBNEiwAoc0-jZThd7r0xs_QGzTqOfsbFb8sTTYOpkqkc9ZPYw8Gg4zwizvLqxaBaxoCB6wQAvD_BwE (assessed on 29/10/2024)
Łukasiewicz S, Czeczelewski M, Forma A, Baj J, Sitarz R, Stanisławek A. Breast cancer—epidemiology, risk factors, classification, prognostic markers, and current treatment strategies—an updated review. Cancers. 2021 August;13(17):4287, https://doi.org/10.3390/cancers13174287
Khan R, Javed U, Rehman AU. Comparison between the Young and Elderly Diagnosed Patients of Carcinoma of the Breast: Breast Carcinoma in Young and Elderly Patients. Pakistan Journal of Health Sciences. 2024 October:32-7. https://doi.org/10.1634/theoncologist.2019-0982
Jabeen S, Zakar R, Zakar MZ, Fischer F. Experiences of family caregivers in dealing with cases of advanced breast cancer: a qualitative study of the sociocultural context in Punjab, Pakistan. BMC Public Health. 2024 August;24(1):1030.
https://doi.org/10.1186/s12889-024-18404-1
Globocan Pakistan; https://canscreen5.iarc.fr/?page=countryfactsheet&q=PAK(assesed on 29/09/2024)
Iftikhar B, Zeeshan S, Shareef S, Haider Z, Naqvi DMAFA IM. Socio-Demographic, Physical and Clinical Risk Factors of Breast Cancer Patients in Pakistan. History of Medicine. 2024 October;10(2):177-89. DOI: 10.17720/2409-5834.v10.2.2024.019
Naz S, Siddiqui M, Memon AI, Bhatti AM, Hussain ZI. Analysis of Breast Cancer Receptors Status and Molecular Subtypes Among Female Population. Pakistan Journal of Medical & Health Sciences. 2023;17(01):656-. DOI: https://doi.org/10.53350/pjmhs2023171656
Sørlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proceedings of the national academy of sciences. 2003 June;100(14):8418-23. https://doi.org/10.1073/pnas.0932692100
Perou CM, Sørlie T, Eisen MB, Van De Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumors. Nature. 2000 june;406(6797):747-52. https://doi.org/10.1073/pnas.0932692100
W. Ma, Y. Zhao, Y. Ji, X. Guo, X. Jian, P. Liu, et al. Breast cancer molecular subtype prediction by mammographic radiomic features, Academic radiology 2019 February Vol. 26 Issue 2 Pages 196-201, https://doi.org/10.1016/j.acra.2018.01.023
A. Atoui, M. Bou Zerdan, A. El Mahmoud, N. Chamseddine, L. Hamad and H. I. Assi Clinical significance of breast cancer molecular subtypes and ki67 expression as a predictive value for pathological complete response following neoadjuvant chemotherapy: experience from a tertiary care center in Lebanon International Journal of Breast Cancer 2022 Feb Vol. 2022 Issue 1 Pages 1218128. https://doi.org/10.1155/2022/1218128
L. Yin, J.-J. Duan, X.-W. Bian and S.-c. Yu, Triple-negative breast cancer molecular subtyping and treatment progress, Breast Cancer Research 2020 June Vol. 22 Pages 1-13
https://doi.org/10.1186/s13058-020-01296-5
S. Zhao, D. Ma, Y. Xiao, X. M. Li, J. L. Ma, H. Zhang, et al. Molecular subtyping of triple‐negative breast cancers by immunohistochemistry: molecular basis and clinical relevance The oncologist 2020 April Vol. 25 Issue 10 Pages e1481-e1491
doi: 10.21037/atm.2020.03.194
Protocol for Examining Resection Specimens from Patients with Invasive Carcinoma of the Breast; College of American Pathologists [Protocol Posting Date: June 2021]. Available from: http ://documents.cap.org/protocols/Breast.Invasive_4.5.0.0.REL_CAPCP.pdf
Seventh Edition © 2010 American Joint Committee on Cancer. All rights reserved. The AJCC Cancer Staging Manual is the Official Publication of the American Joint Committee on Cancer
Mohammed AA. The clinical behavior of different molecular subtypes of breast cancer. Cancer Treatment and Research Communications. 2021Oct;29:100469. https://doi.org/10.1016/j.ctarc.2021.100469
S. Paramita, E. N. Raharjo, M. Niasari, F. Azizah and N. A. Hanifah. Luminal B is the most common intrinsic molecular subtype of invasive ductal breast carcinoma patients in East Kalimantan, Indonesia. Asian Pacific journal of cancer prevention: APJCP 2019 Aug Vol. 20 Issue 8 Pages 2247
doi: 10.31557/APJCP.2019.20.8.2247
Pandit P, Patil R, Palwe V, Gandhi S, Patil R, Nagarkar R. Prevalence of molecular subtypes of breast cancer: a single institutional experience of 2062 patients. European Journal of Breast Health. 2020 Nov;16(1):39. doi: 10.5152/ejbh.2019.4997
Soliman NA, Yussif SM. Ki-67 as a prognostic marker according to breast cancer molecular subtype. Cancer biology & medicine. 2016;13(4):496. doi: 10.20892/j.issn.2095-3941.2016.0066
Al-Thoubaity FK. Molecular classification of breast cancer: A retrospective cohort study. Annals of medicine and surgery. 2020 Dec;49:44-8. https://doi.org/10.1016/j.amsu.2019.11.021
Park S, Koo JS, Kim MS, Park HS, Lee JS, Lee JS, et al. Characteristics and outcomes according to molecular subtypes of breast cancer as classified by a panel of four biomarkers using immunohistochemistry. The Breast. 2012 Aug;21(1):50-7. https://doi.org/10.1016/j.breast.2011.07.008
Elidrissi Errahhali M, Elidrissi Errahhali M, Ouarzane M, El Harroudi T, Afqir S, Bellaoui M. First report on molecular breast cancer subtypes and their clinicopathological characteristics in Eastern Morocco: series of 2260 cases. BMC women's health. 2017 Jan;17:1-11. https://doi.org/10.1186/s12905-016-0361-z
Henna N, Shafqat F, Rehman MU, Fakhr SA, Anjum S, Sameen S, et al. Clinicopathological characteristics of molecularly classified groups of invasive ductal breast carcinoma in Pakistani women. Pakistan Journal of Medicine and Dentistry. 2022;11(2):3-8 DOI: https://doi.org/10.36283/PJMD11-2/002
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Pakistan Journal of Medicine and Dentistry
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access article distributed under the terms of the CreativeCommons Attribution License (CC BY) 4.0 https://creativecommons.org/licenses/by/4.0/
Metrics
How to Cite
